According to enterprise data, Qingdao Shenlong Biological Medicine Co., Ltd. was established on 2019-1-15, with a registered capital of 30 million RMB and 4 insured persons. Is a national high-tech enterprise focusing on pharmaceutical manufacturing. The company has been awarded the qualifications and honors of "National High-tech Enterprise" and "National Small and Medium-sized Technology Enterprise".
In terms of intellectual property rights, Qingdao Shenlong Biomedical Co., Ltd. owns 1 software copyrights and 460 patent information. In addition, Qingdao Shenlong Biomedical Co., Ltd. also invested in five enterprises, directly holding 1 enterprise.